Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, CRISPR Therapeutics AG (NASDAQ: CRSP) closed at $62.94 up 6.55% from its previous closing price of $59.07. In other words, the price has increased by $6.55 from its previous closing price. On the day, 2.78 million shares were traded. CRSP stock price reached its highest trading level at $63.1 during the session, while it also had its lowest trading level at $60.59.
Ratios:
For a deeper understanding of CRISPR Therapeutics AG’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.61 and its Current Ratio is at 16.61. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The Stock’s future direction. In the most recent recommendation for this company, JP Morgan on September 18, 2025, initiated with a Overweight rating and assigned. The Stock a target price of $70.
On February 14, 2025, Evercore ISI Upgraded its rating to Outperform which previously was In-line and also upped its target price recommendation from $60 to $99. TD Cowen Upgraded its Sell to Hold on February 12, 2025, while the target price for. The Stock was maintained at $35.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 18 ’25 when Kulkarni Samarth sold 13,081 shares for $58.15 per share. The transaction valued at 760,660 led to the insider holds 207,004 shares of the business.
Treco Douglas A bought 20,000 shares of CRSP for $1,140,600 on Aug 06 ’25. The Director now owns 22,000 shares after completing the transaction at $57.03 per share. On Jul 16 ’25, another insider, George Simeon, who serves as the Director of the company, bought 989,812 shares for $52.03 each. As a result, the insider paid 51,499,918 and bolstered with 1,730,179 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRSP now has a Market Capitalization of 5724419584 and an Enterprise Value of 4218634496. For. The Stock, the TTM Price-to-Sale (P/S) ratio is 150.44 while its Price-to-Book (P/B) ratio in mrq is 3.25. Its current Enterprise Value per Revenue stands at 110.871 whereas that against EBITDA is -9.648.
Stock Price History:
The Beta on a monthly basis for CRSP is 1.81, which has changed by 0.30635118 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, CRSP has reached a high of $71.13, while it has fallen to a 52-week low of $30.04. The 50-Day Moving Average of. The Stock is 10.07%, while the 200-Day Moving Average is calculated to be 38.06%.
Shares Statistics:
For the past three months, CRSP has traded an average of 3.19M shares per day and 2395620 over the past ten days. A total of 88.38M shares are outstanding, with a floating share count of 86.10M. Insiders hold about 5.33% of the company’s shares, while institutions hold 77.10% stake in the company. Shares short for CRSP as of 1756425600 were 22074375 with a Short Ratio of 6.93, compared to 1753920000 on 23446400. Therefore, it implies a Short% of Shares Outstanding of 22074375 and a Short% of Float of 27.41.
Earnings Estimates
Its stock is currently analyzed by 14.0 different market analysts. The consensus estimate for the next quarter is -$1.12, with high estimates of $0.16 and low estimates of -$1.63.
Analysts are recommending an EPS of between -$4.16 and -$7.33 for the fiscal current year, implying an average EPS of -$6.19. EPS for the following year is -$4.64, with 17.0 analysts recommending between -$2.25 and -$6.71.
Revenue Estimates
A total of 23 analysts have provided revenue estimates for CRSP’s current fiscal year. The highest revenue estimate was $128.26M, while the lowest revenue estimate was $1.76M, resulting in an average revenue estimate of $34.05M. In the same quarter a year ago, actual revenue was $37.31M
